Celebrex is a nonsteroidal anti-inflammatory drug (NSAID) that is used to treat pain, arthritis, and painful menstrual periods. It is not recommended for use in pregnancy from 20 weeks onwards, as it can cause serious heart or kidney problems in the unborn baby and possible complications with the pregnancy. If deemed necessary, it should be used at the lowest effective dose for the shortest time possible.
Characteristics | Values |
---|---|
Safety | Celebrex is not safe to take during pregnancy, especially during the last 20 weeks. |
FDA Pregnancy Category | C, then D from 30 weeks of gestation onward. |
Risk to Foetus | Can cause serious heart or kidney problems in the unborn baby and possible complications with pregnancy. |
Risk to Mother | May impair female fertility. |
What You'll Learn
Celebrex is contraindicated during the last 20 weeks of pregnancy
The US Food and Drug Administration (FDA) has warned that NSAIDs should be avoided in pregnancy at 20 weeks or later. This is because the unborn baby's kidneys produce most of the amniotic fluid at this stage, so kidney problems can lead to low levels of fluid. The FDA has received reports of low amniotic fluid levels or kidney problems in mothers who took NSAIDs while pregnant, with some cases resulting in newborn death.
NSAIDs, including Celebrex, can also cause serious gastrointestinal adverse events such as bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. Elderly patients and those with a history of peptic ulcer disease and/or GI bleeding are at greater risk for serious GI events.
Therefore, it is important to consult a doctor before taking any medication during pregnancy, as they will be able to advise on the benefits and risks of the medication.
Senna's Safety for Early Pregnancy: A Delicate Balance
You may want to see also
It may cause serious heart or kidney problems in the unborn baby
Celebrex is a nonsteroidal anti-inflammatory drug (NSAID) that is used to treat pain, arthritis, and painful menstrual periods. It is not recommended for use in pregnancy from 20 weeks until delivery. If your doctor decides that you need to use this medication between 20 and 30 weeks of pregnancy, you should use the lowest effective dose for the shortest possible time. You should not use this medication after 30 weeks of pregnancy.
Taking an NSAID during the last 20 weeks of pregnancy can cause serious heart or kidney problems in the unborn baby. In animal studies, pregnant animals were given this medication and had some babies born with problems. No well-controlled studies have been done in humans. Therefore, this medication may be used if the potential benefits to the mother outweigh the potential risks to the unborn child.
Use of NSAIDs in pregnant women can cause premature closure of the fetal ductus arteriosus and fetal renal dysfunction leading to oligohydramnios and, in some cases, neonatal renal impairment. Embryofetal risks of NSAID use in women in the first or second trimesters of pregnancy are inconclusive. Embryo-fetal deaths and an increase in diaphragmatic hernias were observed in rats administered this drug during the period of organogenesis.
In summary, taking Celebrex during pregnancy, especially in the last 20 weeks, may cause serious heart or kidney problems in the unborn baby. It is important to consult with a doctor to weigh the potential benefits and risks before taking this medication during pregnancy.
Dandelion Root in Early Pregnancy: Exploring Safety Concerns
You may want to see also
Celebrex is categorised as a C and D risk during pregnancy
The FDA's categorisation is based on animal studies, which have shown that administering Celebrex to pregnant animals resulted in some babies being born with problems. However, no well-controlled studies have been conducted in humans, so the full extent of the risks to an unborn baby when this medication is taken during pregnancy is not yet fully understood.
It is important to note that taking a nonsteroidal anti-inflammatory drug (NSAID) like Celebrex during the last 20 weeks of pregnancy can cause serious heart or kidney problems in the unborn baby and possible complications with the pregnancy. Therefore, it is recommended to avoid taking Celebrex during the third trimester of pregnancy. If a doctor determines that the benefits of taking this medication between 20 and 30 weeks of pregnancy outweigh the risks, it should be used at the lowest effective dose for the shortest possible time. Celebrex should not be used after 30 weeks of pregnancy.
Additionally, NSAIDs can impair female fertility and decrease fertility (the ability to have children) in women, so it is not recommended for those attempting to conceive.
Celebrex Use During Pregnancy: Weighing the Risks and Benefits
You may want to see also
It may be prescribed if the benefits outweigh the risks
Celebrex (celecoxib) is a nonsteroidal anti-inflammatory drug (NSAID) that is used to treat pain and inflammation caused by conditions such as arthritis, migraines, and menstrual pain. It is also used to relieve short-term pain due to injuries, medical procedures, or other conditions.
Pregnancy Warnings
The use of NSAIDs in pregnant women can cause premature closure of the fetal ductus arteriosus and fetal renal dysfunction, leading to oligohydramnios and, in some cases, neonatal renal impairment. Embryo-fetal deaths and an increase in diaphragmatic hernias were observed in animal studies.
Benefits Outweighing the Risks
If the benefits of taking NSAIDs during pregnancy are considered to outweigh the risks, it is recommended to:
- Use the lowest effective dose for the shortest duration possible.
- Limit use to between 20 and 30 weeks' gestation.
- Consider ultrasound monitoring of amniotic fluid if NSAID use extends beyond 48 hours.
- Discontinue the NSAID if oligohydramnios occurs.
It is important to note that the use of NSAIDs is not recommended for women attempting to conceive, as it may impair female fertility. Additionally, NSAIDs should be avoided during pregnancy whenever possible, and alternative treatments should be considered.
Weight Training and Early Pregnancy: Exploring Safe Practices
You may want to see also
It may impair fertility in women attempting to conceive
Nonsteroidal anti-inflammatory drugs (NSAIDs) such as Celebrex are not recommended for women attempting to conceive. This is because they may impair fertility. NSAIDs may delay or prevent the rupture of ovarian follicles, which has been associated with reversible infertility in some women.
If you are a woman attempting to conceive, you should consult your doctor about the benefits and risks of taking Celebrex. The doctor will advise you based on your individual circumstances. It is important to note that the use of NSAIDs during pregnancy, especially in the last 20 weeks, can cause serious heart or kidney problems in the unborn baby and possible complications with the pregnancy. Therefore, it is crucial to seek medical advice before taking any medication during pregnancy or when planning to conceive.
Celebrex is a prescription medication used to treat pain, arthritis, and painful menstrual periods. It belongs to the group of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). These drugs work by blocking the chemicals in the body that cause pain and inflammation. While Celebrex can provide effective relief, it is important to carefully consider its use, especially for women who are pregnant or planning to conceive, due to the potential risks associated with its use during this time.
In summary, it is important to avoid taking NSAIDs like Celebrex if you are attempting to conceive, as they may impair fertility. Always consult your doctor for personalized advice regarding your medication and fertility.
Pregnancy and Long-Distance Travel: Exploring Safe Mobility for Expectant Mothers
You may want to see also
Frequently asked questions
No, it is not recommended to take Celebrex during pregnancy. It is a nonsteroidal anti-inflammatory drug (NSAID) and can cause serious heart or kidney problems in the unborn baby and possible complications with your pregnancy.
Taking an NSAID during the last 20 weeks of pregnancy can cause premature closure of the fetal ductus arteriosus and fetal renal dysfunction leading to oligohydramnios and, in some cases, neonatal renal impairment. Embryo-fetal deaths and an increase in diaphragmatic hernias were also observed in animal studies.
Consult your doctor immediately and seek medical advice.
Yes, there may be alternative treatments. Consult your doctor to discuss other options.